QIAGEN powered by

Webinars and events

Loading Events

« All Events

A breakthrough for rare disease: Completing the Clinical exome gap!

October 19, 2023 @ 11:00 am - 12:00 pm

In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled manually curated content and bibliography.

In this webinar, we will demonstrate how QCI Interpret is expanding its literature coverage enabling easy and efficient variant filtering workflow, based on bibliography and on patient’s phenotype. This new feature provides greater control over bibliography context, allowing users to only look at publications where the causative variant is associated with a specific disease. In addition, the release provides AI-enhanced phenotype-driven ranking. Using this approach that has been trained using thousands of solved cases, QCI Interpret for Hereditary Diseases provides superior overall candidate ranking for causative variants in rare diseases. The new variant-ranking approach is enhanced by taking into account additional variant related variables supported also by AI, as well as the patient’s symptoms, and all of the manually curated literature in the QIAGEN Knowledge Base to give the best possible chance of reaching an accurate diagnosis.

Learning objectives:

  • Learn about QCI Interpret’ s new AI bibliography content providing expanded clinical exome coverage, due to the combination of the AI-derived literature references with QIAGEN’s unrivalled manual curation.
  • Learn about QCI Interpret gives users the best possible chance of reaching an accurate diagnosis by providing phenotype-driven ranking that considers the detected mutations, the patient’s symptoms, and all the content in the QIAGEN Knowledge Base.
  • View live demonstration of unique features in QCI Interpret, which can drastically reduce the time spent on solving a case, resulting in faster turnaround time and an accurate assessment of a case.

Details

Date: October 19, 2023
Time:
 11:00 am - 12:00 pm
Register for event
Event Categories:
,
Event Tags:
,

Venue

Global

Other

Category
Clinical, Webinar
Register for event

On-demand Webinars


  • Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis

    Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the impact of a new drug that has already been through the arduous R&D process for a disease or cancer. Drug repurposing can take this concept and expand on it by looking for other diseases with similar drug target biology. The logic is if...

  • Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. This session is for part I of this training. In this session, you'll learn to use QIAGEN CLC Genomics Workbench to perform se...

  • Part II: Single-cell RNA sequencing data interpretation using QIAGEN Ingenuity Pathway Analysis

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. In this session, we'll explore how you can take your scRNA-seq differential expression results produced from QIAGEN CLC Genom...

  • Immune repertoire analysis using QIAGEN CLC Genomics Workbench

    The composition of the immune repertoire, consisting of the T cell and B cell receptors (TCR and BCR), is important for an organism's adaptive immune system and plays a pivotal role in an individual's overall health. Understanding the complex array of TCR and BCR allows for developing precision medicine and immunotherapy. Analyzing next-generation sequencing (NGS) dat...

  • Compare and contextualize your results using QIAGEN Ingenuity Pathway Analysis

    Take your QIAGEN Ingenuity Pathway Analysis (IPA) analyses to the next level by comparing them to your own analyses (different time points, treatments, cell lines, diseases and more) or to a library of over 100K precomputed datasets to find similar or opposite biological signatures. Identify key genes or entities and then explore how they are expressed across normal t...

  • Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

    In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands. Using public data from GTEx (normal tissue), GEO, cancer collections and more, you'll learn how to use Omicsoft Lands to: • Investigate a drug target or biom...